140 related articles for article (PubMed ID: 31838086)
21. MDA5 complements TLR3 in suppression of neuroblastoma.
Hsu WM; Huang CC; Lee HY; Wu PY; Wu MT; Chuang HC; Lin LL; Chuang JH
Oncotarget; 2015 Sep; 6(28):24935-46. PubMed ID: 26208481
[TBL] [Abstract][Full Text] [Related]
22. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C
Lung Cancer; 2018 Jun; 120():34-45. PubMed ID: 29748013
[TBL] [Abstract][Full Text] [Related]
23. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.
Borchert S; Wessolly M; Schmeller J; Mairinger E; Kollmeier J; Hager T; Mairinger T; Herold T; Christoph DC; Walter RFH; Eberhardt WEE; Plönes T; Wohlschlaeger J; Aigner C; Schmid KW; Mairinger FD
BMC Cancer; 2019 Jan; 19(1):108. PubMed ID: 30700254
[TBL] [Abstract][Full Text] [Related]
25. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.
Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L
Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772
[TBL] [Abstract][Full Text] [Related]
26. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
27. Sub-lethal ultraviolet B irradiation and Poly I:C treatment synergistically induced apoptosis of HaCaT cells through NF-κB pathway.
Otkur W; Liu W; Wang J; Jia X; Huang D; Wang F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Mol Immunol; 2018 Jul; 99():19-29. PubMed ID: 29674236
[TBL] [Abstract][Full Text] [Related]
28. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells.
Weber A; Kirejczyk Z; Besch R; Potthoff S; Leverkus M; Häcker G
Cell Death Differ; 2010 Jun; 17(6):942-51. PubMed ID: 20019748
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma.
Kang Y; Ding M; Tian G; Guo H; Wan Y; Yao Z; Li B; Lin D
Oncol Rep; 2013 Jul; 30(1):313-9. PubMed ID: 23624653
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway.
Nomi N; Kodama S; Suzuki M
Oncol Rep; 2010 Jul; 24(1):225-31. PubMed ID: 20514466
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).
Sun R; Zhang Y; Lv Q; Liu B; Jin M; Zhang W; He Q; Deng M; Liu X; Li G; Li Y; Zhou G; Xie P; Xie X; Hu J; Duan Z
J Biol Chem; 2011 May; 286(18):15918-28. PubMed ID: 21367858
[TBL] [Abstract][Full Text] [Related]
32. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
Lee S; Yoon CY; Byun SS; Lee E; Lee SE
J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells.
Lee YJ; Lee GJ; Yi SS; Heo SH; Park CR; Nam HS; Cho MK; Lee SH
Food Chem Toxicol; 2016 Nov; 97():96-107. PubMed ID: 27591926
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
[TBL] [Abstract][Full Text] [Related]
35. Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.
Cregan S; Breslin M; Roche G; Wennstedt S; MacDonagh L; Albadri C; Gao Y; O'Byrne KJ; Cuffe S; Finn SP; Gray SG
Int J Oncol; 2017 Mar; 50(3):1044-1052. PubMed ID: 28197626
[TBL] [Abstract][Full Text] [Related]
36. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
[TBL] [Abstract][Full Text] [Related]
37. FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.
McLaughlin KA; Nemeth Z; Bradley CA; Humphreys L; Stasik I; Fenning C; Majkut J; Higgins C; Crawford N; Holohan C; Johnston PG; Harrison T; Hanna GG; Butterworth KT; Prise KM; Longley DB
Mol Cancer Ther; 2016 Oct; 15(10):2432-2441. PubMed ID: 27474150
[TBL] [Abstract][Full Text] [Related]
38. Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2.
Mikulandra M; Kobescak A; Verillaud B; Busson P; Matijevic Glavan T
Cell Oncol (Dordr); 2019 Feb; 42(1):29-40. PubMed ID: 30182341
[TBL] [Abstract][Full Text] [Related]
39. Poly (I:C) therapy decreases cerebral ischaemia/reperfusion injury via TLR3-mediated prevention of Fas/FADD interaction.
Zhang X; Ha T; Lu C; Lam F; Liu L; Schweitzer J; Kalbfleisch J; Kao RL; Williams DL; Li C
J Cell Mol Med; 2015 Mar; 19(3):555-65. PubMed ID: 25351293
[TBL] [Abstract][Full Text] [Related]
40. Contrasting effects of glutamine deprivation on apoptosis induced by conventionally used anticancer drugs.
Valter K; Chen L; Kruspig B; Maximchik P; Cui H; Zhivotovsky B; Gogvadze V
Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):498-506. PubMed ID: 27993669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
